Herbas VPB

Print
EN | LT
LT - Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination
EN - Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/00
A61P 35/00
European patent
(11) Number of the document 2042191
(13) Kind of document T
(96) European patent application number 08164900.6
Date of filing the European patent application 2008-09-23
(97) Date of publication of the European application 2009-04-01
(45) Date of publication and mention of the grant of the patent 2013-01-02
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
960414 P 2007-09-28 US
Inventors
(72)
Chiarle, Roberto, IT
Inghirami, Giorgio, IT
Forni, Guido, IT
Grantee
(73) Chiarle, Roberto, Corso Vittorio Veneto, 70, 12038 Savigliano (CN), IT
Inghirami, Giorgio, Frazione Ranello, 71, 14022 Castelnuovo Don Bosco (AT), IT
Forni, Guido, Via dei Mille, 32, 10123 Torino, IT
Title
(54) Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination
  Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination